Medications & Supplements/Prescription Drugs

Golden State Medical Supply Inc.: Losartan Potassium Tablets Recalled for Potential Carcinogen Impurity

Agency Publication Date: July 9, 2019

Summary

Golden State Medical Supply Inc. is recalling approximately 53,297 bottles of Losartan Potassium (50 mg and 100 mg) tablets. An impurity known as N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) was detected in the active ingredient used to manufacture these blood pressure medications. This impurity is a potential human carcinogen, meaning it could increase the risk of cancer with long-term exposure. These products were distributed to a U.S. government account nationwide.

Risk

The tablets contain a chemical impurity called NMBA that is classified as a probable human carcinogen. While no immediate injuries have been reported, the presence of this substance at levels above safety limits poses a potential long-term health risk to patients.

What You Should Do

Locate your prescription bottle and check for Losartan Potassium 50 mg or 100 mg tablets with NDC codes 60429-317-30, 60429-317-90, 60429-317-10, or 60429-318-90.
Verify the specific lot numbers and expiration dates: for 50 mg tablets, look for lots GS017479, GS017651, or GS017387 with an expiration of 01/2020. For 100 mg tablets, look for lots GS017042, GS017043, GS017044, or GS017541, all with an expiration of 01/2020.
Contact your healthcare provider or pharmacist immediately for guidance before you stop taking the medication, as stopping blood pressure medicine abruptly can pose a health risk.
Return any unused affected product to your pharmacy to receive a refund.
Contact Golden State Medical Supply Inc. at their Camarillo, California headquarters or your dispensing pharmacy for further instructions regarding the return process.
For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Full Refund

Pharmacy refund and medical consultation

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Losartan Potassium, 50 mg tablets (30 count bottle)

Model:

NDC 60429-317-30

Recall #: D-1462-2019

Lot Numbers:

GS017479 (Exp 01/2020)

Date Ranges: 01/2020

Product: Losartan Potassium, 50 mg tablets (90 count bottle)

Model:

NDC 60429-317-90

Recall #: D-1463-2019

Lot Numbers:

GS017651 (Exp 01/2020)

Date Ranges: 01/2020

Product: Losartan Potassium, 50 mg tablets (1000 count bottle)

Model:

NDC 60429-317-10

Recall #: D-1464-2019

Lot Numbers:

GS017387 (Exp 01/2020)

Date Ranges: 01/2020

Product: Losartan Potassium, 100 mg tablets (90 count bottle)

Model:

NDC 60429-318-90

Recall #: D-1465-2019

Lot Numbers:

GS017042 (Exp 01/2020)

GS017043 (Exp 01/2020)

GS017044 (Exp 01/2020)

GS017541 (Exp 01/2020)

Date Ranges: 01/2020

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 83161

Status: Resolved

Manufacturer: Golden State Medical Supply Inc.

Sold By: U.S. government account

Manufactured In: United States

Units Affected: 4 products (4,037 bottles (121,110 tablets); 14,955 bottles (1,345,950 tablets); 1,470 bottles (1,470,000 tablets); 32,835 bottles (2,955,150 tablets))

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Locate your prescription bottle and check for Losartan Potassium 50 mg or 100 mg tablets with NDC codes 60429-317-30, 60429-317-90, 60429-317-10, or 60429-318-90.

Verify the specific lot numbers and expiration dates: for 50 mg tablets, look for lots GS017479, GS017651, or GS017387 with an expiration of 01/2020. For 100 mg tablets, look for lots GS017042, GS017043, GS017044, or GS017541, all with an expiration of 01/2020.

Contact your healthcare provider or pharmacist immediately for guidance before you stop taking the medication, as stopping blood pressure medicine abruptly can pose a health risk.

Return any unused affected product to your pharmacy to receive a refund.

Contact Golden State Medical Supply Inc. at their Camarillo, California headquarters or your dispensing pharmacy for further instructions regarding the return process.

For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Affected Products

Product: Losartan Potassium, 50 mg tablets (30 count bottle)

Model:

NDC 60429-317-30

Recall #: D-1462-2019

Lot Numbers:

GS017479 (Exp 01/2020)

Date Ranges: 01/2020

Product: Losartan Potassium, 50 mg tablets (90 count bottle)

Model:

NDC 60429-317-90

Recall #: D-1463-2019

Lot Numbers:

GS017651 (Exp 01/2020)

Date Ranges: 01/2020

Product: Losartan Potassium, 50 mg tablets (1000 count bottle)

Model:

NDC 60429-317-10

Recall #: D-1464-2019

Lot Numbers:

GS017387 (Exp 01/2020)

Date Ranges: 01/2020

Product: Losartan Potassium, 100 mg tablets (90 count bottle)

Model:

NDC 60429-318-90

Recall #: D-1465-2019

Lot Numbers:

GS017042 (Exp 01/2020)

GS017043 (Exp 01/2020)

GS017044 (Exp 01/2020)

GS017541 (Exp 01/2020)

Date Ranges: 01/2020

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 83161

Status: Resolved

Manufacturer: Golden State Medical Supply Inc.

Sold By: U.S. government account

Manufactured In: United States

Units Affected: 4 products (4,037 bottles (121,110 tablets); 14,955 bottles (1,345,950 tablets); 1,470 bottles (1,470,000 tablets); 32,835 bottles (2,955,150 tablets))

Distributed To: Nationwide